Kraig Biocraft Laboratories, Inc

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Post-effective amendment to a registration statement

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Post-effective amendment to a registration statement

Annual report pursuant to Section 13 or 15(d)

Other Events

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Post-effective amendment to a registration statement

Annual report pursuant to Section 13 or 15(d)

Correspondence with the SEC

Letter from the SEC

Entry into a Material Definitive Agreement

General form for quarterly reports under Section 13 or 15(d)

No description available

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

3.02,9.01

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

1.01,2.03,9.01

Correspondence with the SEC

Annual report pursuant to Section 13 or 15(d)

Letter from the SEC

1.01,2.03,8.01,9.01

General form for quarterly reports under Section 13 or 15(d)

1.01,2.03,9.01

Correspondence with the SEC

1.01,2.03,9.01

1.01,2.03,8.01,9.01

Definitive information statement

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

1.01,3.02,8.01,9.01

Correspondence with the SEC

No description available

1.01,2.03,8.01,9.01

8.01,9.01

8.01,9.01

7.01,8.01,9.01

7.01,8.01,9.01

5.07

8.01,9.01

7.01,8.01,9.01

3.02,8.01

8.01

Letter from the SEC

Regulation FD Disclosure

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Rice Jonathan Richard

Thompson Kimberly Kraig

Thompson Kimberly Kraig

Rice Jonathan Richard

Rice Jonathan Richard

Thompson Kimberly Kraig

Thompson Kimberly Kraig

Thompson Kimberly Kraig

Thompson Kimberly Kraig

Thompson Kimberly Kraig

Thompson Kimberly Kraig

Thompson Kimberly Kraig

Thompson Kimberly Kraig

Thompson Kimberly Kraig

Thompson Kimberly Kraig

Thompson Kimberly Kraig

Thompson Kimberly Kraig

Thompson Kimberly Kraig

Thompson Kimberly Kraig

Thompson Kimberly Kraig